Search
for
Sort by
Research 181–210 of 840
- Cyclosporin: applications in small animal dermatology
- Absorption sites of orally administered drugs in the small intestine
- Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Functional identification of the phosphorylation sites of Arabidopsis PIN-FORMED3 for its subcellular localization and biological role
- A discourse on human hair fibers and reflections on the conservation of drug molecules
- 5α-Reduced glucocorticoids: a story of natural selection
- Lymphatic vessels interact dynamically with the hair follicle stem cell niche during skin regeneration <i>in vivo</i>
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Mitoxantrone
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Hair-Thread Tourniquet Syndrome in an Infant With Bony Erosion
- Female type of adult acne: Physiological and psychological considerations and management
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Androgens and Antiandrogens
- No Evidence that 2D:4D is Related to the Number of CAG Repeats in the Androgen Receptor Gene
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Enzyme Treatment of Wool and Specialty Hair Fibers
- Androgens in women
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Cardiovascular risk factors and events in women with androgen excess
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women